BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10494519)

  • 1. Clinical economics of head and neck malignancies.
    Sherman EJ; Ruchlin HS; Holden JS; Pfister DG
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):867-81. PubMed ID: 10494519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic considerations in the care of patients with head and neck malignancies.
    Pfister DG; Ruchlin HS; Elkin EB
    Curr Opin Oncol; 1997 May; 9(3):241-6. PubMed ID: 9229146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer.
    Jansen F; Krebber AM; Coupé VM; Cuijpers P; de Bree R; Becker-Commissaris A; Smit EF; van Straten A; Eeckhout GM; Beekman AT; Leemans CR; Verdonck-de Leeuw IM
    J Clin Oncol; 2017 Jan; 35(3):314-324. PubMed ID: 27918712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic burden of head and neck cancer: a systematic literature review.
    Wissinger E; Griebsch I; Lungershausen J; Foster T; Pashos CL
    Pharmacoeconomics; 2014 Sep; 32(9):865-82. PubMed ID: 24842794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.
    Bereza BG; Machado M; Einarson TR
    Clin Ther; 2009 Jun; 31(6):1279-308. PubMed ID: 19695395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates.
    Ong KJ; Checchi M; Burns L; Pavitt C; Postma MJ; Jit M
    Sex Transm Infect; 2019 Feb; 95(1):28-35. PubMed ID: 30674687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer.
    Acevedo JR; Fero KE; Wilson B; Sacco AG; Mell LK; Coffey CS; Murphy JD
    J Clin Oncol; 2016 Nov; 34(32):3886-3891. PubMed ID: 27551113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluation.
    Meregaglia M; Cairns J; Licitra L; Bossi P
    Eur J Cancer; 2018 Apr; 93():89-98. PubMed ID: 29477796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of head and neck cancer. A literature review.
    Lee JM; Turini M; Botteman MF; Stephens JM; Pashos CL
    Eur J Health Econ; 2004 Feb; 5(1):70-80. PubMed ID: 15452768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical guidelines and payer policies on fusion for the treatment of chronic low back pain.
    Cheng JS; Lee MJ; Massicotte E; Ashman B; Gruenberg M; Pilcher LE; Skelly AC
    Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S144-63. PubMed ID: 21952186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining value-driven care in head and neck oncology.
    Roman BR; Awad MI; Patel SG
    Curr Oncol Rep; 2015 Jan; 17(1):424. PubMed ID: 25416318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economics of squamous cell carcinoma of the head and neck.
    Menzin J; Lines LM; Manning LN
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):68-73. PubMed ID: 17413405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating considerations of cost-effectiveness, affordability, and resource implications in guideline development: article 6 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Hill SR; Olson LG; Falck-Ytter Y; Cruz AA; Atkins D; Baumann M; Jaeschke R; Woitalla T; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):251-5. PubMed ID: 23256167
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.